A systematic comparison of national and international dementia guidelines;Nationale und internationale demenz-leitlinien im vergleich

Fortschritte der Neurologie Psychiatrie

Volumn 71, Issue 6, 2003, Pages 285-295

  Müller, Ulrich ^a   Wolf, H ^a,b   Kiefer, M ^a   Gertz, H J ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMANTADINE; CHOLINESTERASE INHIBITOR; DIHYDROERGOTOXINE; DONEPEZIL; ESTROGEN; GALANTAMINE; GINKGO BILOBA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTINE; NICERGOLINE; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIRACETAM; PYRITINOL; RIVASTIGMINE; SELEGILINE; TACRINE;

CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITION; DEMENTIA; DIAGNOSTIC PROCEDURE; ELECTROENCEPHALOGRAM; EVALUATION; GERMANY; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; PUBLICATION; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; STRUCTURE ANALYSIS; TRAINING;

EID: 18344397744     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39595     Document Type: Review

References (61)

1. Kanowski S, Igl G, Bartholomeyczik S, Brenner H, Großjohann K, Ihl R, Kuhlmey, Schreiber HL, Steinhagen-Thiessen E, Tesch-Römer C, Weyerer S, Wojnar J. Vierter Altenbericht zur Lage der älteren Generation in der Bundesrepublik Deutschland. Risiken, Lebensqualität und Versorgung Hochaltriger - unter besonderer Berücksichtigung demenzieller Erkrankungen. Berlin: Bundesministerium für Familie, Senioren, Frauen und Jugend, 2002
2. Oakley-Browne MA. EBM in practice: psychiatry. Med J Australia 2001; 174: 403-404
3. Lasek R, Müller-Oerlinghausen B. Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft - Ein Instrument zur Qualitätssicherung in der Arzneimitteltherapie. Z Ärztl Fortbild Qualitätssich 1997; 91: 375-383
4. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) und die Ärztliche Zentralstelle für Qualitätssicherung (ÅZQ). Das Leitlinien-Manual von AWMF und ÄZQ. Z Ärztl Fortb Qualitätssicherung 2001; 95 (Suppl 1): 1-84
5. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-1142 [AAN]*
6. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153 [AAN]*
7. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154-1166 [AAN]*
8. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000; 355: 103-106
9. Härter M, Bermejo I, Aschenbrenner A, Berger M. Analyse und Bewertung aktueller Leitlinien zur Diagnostik und Behandlung depressiver Störungen. Fortschr Neurol Psychiat 2001; 69: 390-401
10. Wallesch CW. Leitlinien zur Diagnostik bei Patienten mit Demenz. Akt Neurol 2001; 28: 201-207
11. Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies Scientist Panel on Dementia. Eur J Neurol 2000; 7: 133-144 [EFNS]*
12. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. Br Med J 2001; 323: 334-336
13. Scottish Intercollegiate Guidelines Network. SIGN 50. A Guideline Developers' Handbook. Edinburgh: SIGN, 2002 (www.sign.ac.uk)
14. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA, Tune LE. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. J Am Med Assoc 1997; 278: 1363-1371
15. Wallin A, Brun A, Gustafson L (Hrsg). Swedish Consensus on Dementia Diseases (Acta Neurologica Scandinavica Supplement 157). Køpenhagen: Munksgaard, 1994
16. Scottish Intercollegiate Guidelines Network (SIGN). Interventions in the Management of Behavioural and Psychological Aspects of Dementia: A National Clinical Guideline recommended for use in Scotland. Edinburgh: SIGN, 1998 (www.sign.ac.uk)
17. Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B. Guidelines for managing Alzheimer's disease: part I. Assessment. Am Fam Physician 2002; 65: 2263-2272
18. Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician 2002; 65: 2525-2534
19. American Academy of Neurology. Practice parameter for diagnosis and evaluation of dementia (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994; 44: 2203-2206 [AAN]*
20. Dubinsky RM, Stein AC, Lyons K. Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000; 54: 2205-2211
21. Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG. Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial. Ann Intern Med 1999; 131: 237-246
22. Holloway RG, Gifford DR, Frankel MR, Vickrey BG. A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study. Control Clin Trials 1999; 20: 369-385
23. Work Group on Alzheimer's Disease and Related Dementias. Practice Guideline for the Treatment of Patients with Alzheimer's Disease and other Dementias of Late Life (American Journal of Psychiatry Supplement). Washington: APA Press, 1997 [APA]*
24. Rabins P, Blan W, Bright-Long L, Cohen E, Katz I, Rovner B, Schneider L, Blacker D. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. In: American Psychiatric Association (Hrsg). Guidelines for the Treatment of Psychiatric Disorders: Compendium 2002. Washington: American Psychiatric Press, 2002: 67-135 [APA]*
25. American Psychiatric Association. Practice guideline development process. In: American Psychiatric Association (Hrsg). Guidelines for the Treatment of Psychiatric Disorders: Compendium 2002. Washington: American Psychiatric Press, 2002: 857-863 [APA]*
26. Sainsbury R, Collins C, Duff G, Harrison J, Haydon R, Wilkinson T. Guidelines for the Support and Management of People with Dementia. Wellington: New Zealand Guidelines Group, 1988 (www.nzgg.org.nz) [NZGG]*
27. Milne RJ. National Guidelines Committee for Acetylcholinesterase Inhibitors. Guidelines for the Use of Acetylcholinesterase Inhibitor Drugs in the Treatment of People with Alzheimer's Disease. Wellington: New Zealand Guidelines Group, 2000 (www.nzgg.org.nz) [NZGG]*
28. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can Med Assoc J 1999; 160 (12 Suppl): 1-15 [CCCD]*
29. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. Can Med Assoc 1999; 160: 1738-1742
30. Patterson C, Gauthier S, Bergman H, Cohen C, Feightner JW, Feldman H, Grek A, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci 2001; 28 (Suppl 1): 3-16 [CCCD]*
31. Hogan DB, Jennett P, Freter S, Bergman H, Chertkow H, Gold S, Clarfield AM. Recommendations of the Canadian Consensus Conference on Dementia - dissemination, implementation, and evaluation of impact. Can J Neurol 2001; 28 (Suppl 1): 115-121
32. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (Hrsg). Behandlungsleitlinie Demenz (Praxisleitlinien in Psychiatrie und Psychotherapie 3). Darmstadt: Steinkopff, 2000 [DGPPN]*
33. Petit H, Albarède JL, Bakchine S, Boulliat J, Cogneau J, Darcourt G, Dubois B, Forette F, Franco A, Héres J, Hinault P, Laurent B, Léger JM, Marin La Meslée R, Montagne B, Poncet M, Robert P, Sorbé G, Touchon J, Velas B, Vetel JM. Convergences d'un groupe pluridisciplinaire d'experts français sur les modalités du diagnostic et des thérapeutiques de la maladie d'Alzheimer au stade démentiel. Rev Neurol 2000; 156: 542-552 [GEMA]*
34. The Dementia Study Group of the Italian Neurological Society. Guidelines for the diagnosis of dementia and Alzheimer's disease. Neurol Sci 2000; 21: 187-194 [SIN]*
35. Arzneimittelkommission der deutschen Ärzteschaft. Empfehlungen zur Therapie der Demenz (Arzneiverordnungen in der Praxis). Köln: Arzneimittelkommission der deutschen Ärzteschaft, 2001 (www.ak-dae.de) [AkdÄ]*
36. National Institute for Clinical Excellence. Guidance for the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease (Technical Appraisal Guidance 19). London: National Institute for Clinical Excellence, 2001 (www.nice.org.uk) [NICE]*
37. Ministry of Health. Clinical Practice Guidelines: Dementia. Singapore: Ministry of Health, 2001 (www.gov.sg/moh/pub/cpg/cpg.htm) [MHS]*
38. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036
39. Robles A, Del Ser T, Alom J, Pena-Casanova J. Grupo Asesor del Grupo de Neurología de la Conducta y Demencias de la Sociedad Española de Neurología. Propuesta de criterios para el diagnóstico clínico del deterio cognitivo ligero, la demencia y la enfermedad de Alzheimer. Neurología 2002; 17: 7-32 [SEN]*
40. Diener HC, Hacke W (Hrsg). Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben für die Kommission "Leitlinien" der Deutschen Gesellschaft für Neurologie. Stuttgart: Thieme, 2002 [DGN]*
41. The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation: AGREE Instrument. London: St. George's Hospital Medical School, 2001 (www.agreecollaboration.org)
42. Scheltens P, Fox N, Barkhof F, De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002; 1: 13-21
43. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl 2003; 179: 52-76
44. McMahon PM, Araki SS, Neumann PJ, Harris GJ, Gazelle GS. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease. Radiology 2000; 217: 58-68
45. Meyer GJ, Waters SL, Coenen HH, Luxen A, Maziere B, Langstrom B. PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs). Eur J Nucl Med 1995; 22: 1420-1432
46. Lyketsos CG, Olin J. Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry 2002; 52: 243-252
47. Hirsch RD. Sozio- und Psychotherapie bei Alzheimerkranken. Z Gerontol Geriat 2001; 34: 92-100
48. Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 11: 21-28
49. Rosen CS, Chow HC, Greenbaum MA, Finney JF, Moos RH, Sheikh JI, Yesavage JA. How well are clinicians following dementia practice guidelines? Alzheimer Dis Assoc Disord 2002; 16: 15-23
50. Seidman D. Compliance with guidelines is not the same as evidence-based medicine. J Pediatr 2001; 138: 299-300
51. Shekelle P, Eccles MP, Grimshaw JM, Woolf SH. When should clinical guidelines be updated? Br Med J 2001; 323: 155-157
52. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. Br Med J 1999; 318: 593-596
53. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283-1290
54. Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002; 33: 1834-1839
55. Wilcock G, Mobius HJ, Stoffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002; 17: 297-305
56. Winblad B, Poritis N. Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999; 14: 135-146
57. Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement Geriatr Cogn Disord 2002; 13: 217-224
58. Lundberg N, American Geriatrics Society, British Geriatrics Society, American Academy of Orthopaedic Surgeons Panel on Falls Prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001; 49: 664-672
59. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. Br Med J 1999; 318: 527-530
60. Weidinger P. Leitlinien und ärztliche Berufshaftpflicht. Internist 2001; 42: M118-123
61. Rossor MN. Dementia and driving: European National Guidelines. EFNS Scientist Panel on Dementia. Eur J Neurol 2000; 7: 745